BioPharmX Corp fka BPMX

[Whos_Who]

DERM2018 Sold Out

These are very popular conference's in the Dermatology world!

UPCOMING CONFERENCE

July 20, Las Vegas *sold out*

Due to overwhelming interest, the 2018 Fall Clinical Dermatology Conference® is now *sold out*

Due to overwhelming interest, the 2019 Winter Clinical Dermatology Conference - Hawaii® is now *sold out*.
http://www.clinicaldermconf.org/home/

BioPharmX analysis will be presented at the Dermatology Education Foundation's DERM2018 conference in a poster entitled "Subset Analysis of IGA in Female Demographic in BPX-01 Topical Minocycline Gel Phase 2b Trial for the Treatment of Inflammatory Acne Vulgaris," on July 20 in Las Vegas.

Agenda - Friday, July 20, 2018
1:15 PM - 1:45 PM Acne and Rosacea: New Therapeutic Agents Linda Stein Gold

Linda Stein-Gold, MD, has affiliations
with Galderma, Bayer, Allergan,
BioPharmX, LeoPharma, SunPharma,
Foamix, Promius, Novartis, Aqua/
Almirall, Ortho Dermatologics, Pfizer
(Anacor), Aclaris, Novan, Dermira,
Promius, Valeant, and Medimetriks.
https://www.google.com/url?sa=t&source=web&rct=j&url=https://rosacea-support.org/wp-content/uploads/2018/01/DT_Galderma.pdf&ved=2ahUKEwjh06ri1KzcAhXKylQKHZIyAdwQFjASegQIAhAB&usg=AOvVaw0L8xGJeN_wfCDioC3NICSh

BioPharmX continues to be in ongoing discussions with a number of potential strategic partners regarding interest in the company's BPX-01 product candidate for the treatment of acne. The company continues to assess several written indications of interest and is evaluating the variety of financial and strategic benefits of the various options. Management remains diligent and deliberate in its thoughtful consideration of options as it works to maintain the best interests of the company and its shareholders.